Invention Grant
US08846675B2 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
有权
用于治疗糖尿病和代谢紊乱的N-连接的杂环受体激动剂
- Patent Title: N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
- Patent Title (中): 用于治疗糖尿病和代谢紊乱的N-连接的杂环受体激动剂
-
Application No.: US13463617Application Date: 2012-05-03
-
Publication No.: US08846675B2Publication Date: 2014-09-30
- Inventor: Jingyuan Ma , Christopher J. Rabbat , Jiangao Song , Xin Chen , Imad Nashashibi , Zuchun Zhao , Aaron Novack , Dong Fang Shi , Peng Cheng , Yan Zhu , Alison Murphy
- Applicant: Jingyuan Ma , Christopher J. Rabbat , Jiangao Song , Xin Chen , Imad Nashashibi , Zuchun Zhao , Aaron Novack , Dong Fang Shi , Peng Cheng , Yan Zhu , Alison Murphy
- Applicant Address: US CA Newark
- Assignee: Cymabay Therapeutics, Inc.
- Current Assignee: Cymabay Therapeutics, Inc.
- Current Assignee Address: US CA Newark
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D401/14 ; C07D413/14 ; C07D401/04 ; C07D417/14
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
Public/Granted literature
- US20120322804A1 N-LINKED HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS Public/Granted day:2012-12-20
Information query
